Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study

Journal Article · · Metallomics
DOI:https://doi.org/10.1039/d0mt00222d· OSTI ID:1835301
 [1];  [1];  [2];  [3];  [1];  [4];  [5];  [3];  [1];  [1];  [6]
  1. Univ. of Saskatchewan, Saskatoon, SK (Canada)
  2. Univ. of Saskatchewan, Saskatoon, SK (Canada); Univ. of Louisville, KY (United States)
  3. Univ. of Adelaide, SA (Australia)
  4. Argonne National Lab. (ANL), Lemont, IL (United States)
  5. Canadian Light Source Inc., Saskatoon, SK (Canada); Univ. of Saskatchewan, Saskatoon, SK (Canada)
  6. Univ. of Saskatchewan, Saskatoon, SK (Canada); Univ. of Adelaide, SA (Australia)
8-Hydroxyquinolines (8HQs) comprise a family of metal-binding compounds that have been used or tested for use in numerous medicinal applications, including as treatments for bacterial infection, Alzheimer's disease, and cancer. Two key 8HQs, CQ (5-chloro-7-iodo-8-hydroxyquinoline) and PBT2 (2-(dimethylamino)methyl-5,7-dichloro-8-hydroxyquinoline), have drawn considerable interest and have been the focus of many studies investigating their in vivo properties. These drugs have been described as copper and zinc ionophores because they do not cause metal depletion, as would be expected for a chelation mechanism, but rather cellular accumulation of these ions. In studies of their anti-cancer properties, CQ has been proposed to elicit toxic intracellular copper accumulation and to trigger apoptotic cancer cell death through several possible pathways. In this study we used synchrotron X-ray fluorescence imaging, in combination with biochemical assays and light microscopy, to investigate 8HQ-induced alterations to metal ion homeostasis, as well as cytotoxicity and cell death. We used the bromine fluorescence from a bromine labelled CQ congener (5,7-dibromo-8-hydroxyquinoline; B2Q) to trace the intracellular localization of B2Q following treatment and found that B2Q crosses the cell membrane. We also found that 8HQ co-treatment with Cu(ii) results in significantly increased intracellular copper and significant cytotoxicity compared with 8HQ treatments alone. PBT2 was found to be more cytotoxic, but a weaker Cu(ii) ionophore than other 8HQs. Moreover, treatment of cells with copper in the presence of CQ or B2Q resulted in copper accumulation in the nuclei, while PBT2-guided copper was distributed near to the cell membrane. Furthermore, these results suggest that PBT2 may be acting through a different mechanism than that of other 8HQs to cause the observed cytotoxicity.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
Canada Foundation for Innovation (CFI); Natural Sciences and Engineering Research Council of Canada (NSERC); USDOE Office of Science (SC), Basic Energy Sciences (BES); University of Saskatchewan
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1835301
Journal Information:
Metallomics, Journal Name: Metallomics Journal Issue: 12 Vol. 12; ISSN 1756-5901
Publisher:
Royal Society of ChemistryCopyright Statement
Country of Publication:
United States
Language:
English

References (78)

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial journal December 2003
Structures of the Copper and Zinc Complexes of PBT2, a Chelating Agent Evaluated as Potential Drug for Neurodegenerative Diseases: Structures of the Copper and Zinc Complexes of PBT2, a Chelating Agent Evaluated as Potential Drug for Neurodegenerative Diseases journal January 2017
Determination of chinoform in biological fluids and nervous tissues of the dog by gas chromatography-mass spectrometry journal February 1987
Clioquinol-Zinc Chelate: A Candidate Causative Agent of Subacute Myelo-Optic Neuropathy journal October 1998
Clioquinol effects on tissue chelatable zinc in mice journal October 2003
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion journal December 2002
Human serum albumin coordinates Cu(II) at its N-terminal binding site with 1 pM affinity journal May 2007
Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells journal October 2009
Copper and the brain noradrenergic system journal November 2019
Copper Concentration in Body Tissues and Fluids in Normal Subjects of Southern Poland journal May 2007
A 2-Substituted 8-Hydroxyquinoline Stimulates Neural Stem Cell Proliferation by Modulating ROS Signalling journal June 2016
Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain journal December 1994
Identification of green pigment and analysis of clioquinol in specimens from patients with subacute myelo-optico-neuropathy journal August 1973
Trace metal levels in commercially prepared tissue culture media journal January 1980
Regulation of metallothionein gene expression by oxidative stress and metal ions journal January 2000
Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice journal May 2001
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo journal March 2003
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial journal September 2008
Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells journal March 2004
Promises and Pitfalls of Metal Imaging in Biology journal January 2018
The antitumor activity of zinc(II) and copper(II) complexes with 5,7-dihalo-substituted-8-quinolinoline journal November 2013
Hydroxyquinoline based binders: Promising ligands for chelatotherapy? journal March 2011
Simple and mixed complexes of copper(II) with 8-hydroxyquinoline derivatives and amino acids: Characterization in solution and potential biological implications journal March 2018
Clioquinol induces autophagy in cultured astrocytes and neurons by acting as a zinc ionophore journal June 2011
Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ journal July 2008
Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases journal February 2012
Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion journal August 2011
Unravelling the interaction mechanism between clioquinol and bovine serum albumin by multi-spectroscopic and molecular docking approaches journal June 2019
Clioquinol induces DNA double-strand breaks, activation of ATM, and subsequent activation of p53 signaling journal September 2012
Copper Complexes with 1,10-Phenanthroline Derivatives: Underlying Factors Affecting Their Cytotoxicity journal June 2020
Elemental and Chemically Specific X-ray Fluorescence Imaging of Biological Systems journal January 2014
The Evaluation of Liposome-Water Partitioning of 8-Hydroxyquinolines and Their Copper Complexes journal February 2006
Structure and Behavior of Organic Analytical Reagents. III. Stability of Chelates of 8-Hydroxyquinoline and Analogous Reagents 1 journal November 1952
Copper-Dependent Cytotoxicity of 8-Hydroxyquinoline Derivatives Correlates with Their Hydrophobicity and Does Not Require Caspase Activation journal November 2012
Desferoxamine (DFO) – Mediated Iron Chelation: Rationale for a Novel Approach to Therapy for Brain Cancer journal May 2004
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma journal August 2008
The neurobiology of zinc in health and disease journal May 2005
8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential journal January 2015
A Golgi-targeting fluorescent probe for labile Fe( ii ) to reveal an abnormal cellular iron distribution induced by dysfunction of VPS35 journal January 2019
Silicon nitride as a versatile growth substrate for microspectroscopic imaging and mapping of individual cells journal January 2010
Clioquinol targets zinc to lysosomes in human cancer cells journal December 2008
Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer journal May 2011
A role for heme in Alzheimer's disease: Heme binds amyloid   and has altered metabolism journal July 2004
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model journal August 2005
Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+ journal May 2009
Bioavailable copper modulates oxidative phosphorylation and growth of tumors journal November 2013
Clioquinol promotes the degradation of metal-dependent amyloid-  (A ) oligomers to restore endocytosis and ameliorate A  toxicity journal March 2014
The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity journal November 2013
Clioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer's Disease journal December 2004
Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity journal June 2006
The Anti-neurodegeneration Drug Clioquinol Inhibits the Aging-associated Protein CLK-1 journal January 2009
Iron bound to the lipophilic iron chelator, 8-hydroxyquinoline, causes DNA strand breakage in cultured lung cells journal January 1996
Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer’s Disease and Nondemented Elderly Controls journal December 2015
Nanoscopic X-ray imaging and quantification of the iron cellular architecture within single fibroblasts of Friedreich's ataxia patients journal January 2020
Aging results in copper accumulations in glial fibrillary acidic protein-positive cells in the subventricular zone journal July 2013
Copper and Angiogenesis: Unravelling a Relationship key to Cancer Progression journal January 2009
Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer’s disease journal April 2009
The Alzheimer’s therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity: Metal chaperone activity of PBT2 journal August 2011
Effects of 5-Chloro-7-iodo-8-hydroxyquinoline (Clioquinol) and Nerve Growth Factor on DNA, RNA and Protein Syntheses in Neonatal Rat Superior Cervical Ganglia journal October 1988
Clioquinol Promotes Cancer Cell Toxicity through Tumor Necrosis Factor α Release from Macrophages journal October 2007
Differentiated Rat Glial Cell Strain in Tissue Culture journal July 1968
Copper is taken up efficiently from albumin and α 2 -macroglobulin by cultured human cells by more than one mechanism journal September 2008
Anticancer Activity of the Antibiotic Clioquinol journal April 2005
Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts journal February 2007
High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines journal January 2018
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells journal September 2005
Copper deficiency myeloneuropathy: A clue to clioquinol-induced subacute myelo-optic neuropathy? journal August 2008
Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry journal September 2010
Age-Associated Changes of Brain Copper, Iron, and Zinc in Alzheimer's Disease and Dementia with Lewy Bodies journal October 2014
Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer’s Disease: A Replication Study and Meta-Analyses journal August 2015
The Metal Chelating and Chaperoning Effects of Clioquinol: Insights from Yeast Studies journal September 2010
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses journal April 2010
Clioquinol Reduces Zinc Accumulation in Neuritic Plaques and Inhibits the Amyloidogenic Pathway in AβPP/PS1 Transgenic Mouse Brain journal March 2012
Regional Distributions of Iron, Copper and Zinc and Their Relationships With Glia in a Normal Aging Mouse Model journal December 2019
The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy journal September 2018
Iron Metabolism in Cancer journal December 2018
Iron as a Central Player and Promising Target in Cancer Progression journal January 2019
Cellular Zn depletion by metal ion chelators (TPEN, DTPA and chelex resin) and its application to osteoblastic MC3T3-E1 cells journal January 2007

Similar Records

Solution Chemistry of Copper(II) Binding to Substituted 8-Hydroxyquinolines
Journal Article · Tue Sep 15 20:00:00 EDT 2020 · Inorganic Chemistry · OSTI ID:1769889

Effects of intracellular iron overload on cell death and identification of potent cell death inhibitors
Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23136952

Anti-Prostate Cancer Activity of 8-Hydroxyquinoline-2-Carboxaldehyde–Thiosemicarbazide Copper Complexes by Fluorescent Microscopic Imaging
Journal Article · Tue Nov 14 23:00:00 EST 2017 · Journal of Fluorescence (Online) · OSTI ID:22795737